[Mechanism and overcome against drug resistance to imatinib for treatment of chronic myeloid leukemia]. [electronic resource]
- Gan to kagaku ryoho. Cancer & chemotherapy May 2011
- 749-53 p. digital
Publication Type: Journal Article
0385-0684
Antineoplastic Agents--therapeutic use Benzamides Drug Resistance, Neoplasm Fusion Proteins, bcr-abl--genetics Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Organic Cation Transporter 1--metabolism Piperazines--therapeutic use Pyrimidines--therapeutic use